Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
D000818:Animals; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D008297:Male; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000503:physiopathology*; D010546:Perphenazine / Q000494:pharmacology*; D010868:Pimozide / Q000494:pharmacology*; D010902:Pituitary Gland / Q000378:metabolism / Q000503:physiopathology*; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000503:physiopathology*; D011388:Prolactin / Q000096:biosynthesis / Q000378:metabolism; D051381:Rats; D014316:Tritium
D018492:Dopamine Antagonists; D014316:Tritium; D010868:Pimozide; D011388:Prolactin; D010546:Perphenazine; D007930:Leucine; D006220:Haloperidol; D004298:Dopamine